AbCellera
BC - VancouverBiotechnology
Focus: AbCellera is a Vancouver-based therapeutic antibody discovery company founded in 2015, leveraging AI and proprietary platforms to identify novel antibodies across five therapeutic areas. With 501-1,000 employees, it operates at mid-cap biotech scale with a focus on translating discovery into clinical programs.
Profile data last refreshed 6h ago · AI intelligence enriched 2w ago
Employees
501-1000
Open Jobs
34+4 this month
Stable — net +4 jobs in 30d
17 added, 13 removed. Backfill posture.
Should You Work at AbCellera?
AI assessmentIdeal for discovery and early development specialists seeking high platform impact and rapid scaling in a pre-peak biotech, but requires comfort with early-stage clinical risk and undisclosed financial footing.
Why Work Here
- Expanding pipeline with 7 active programs across Phase 1–3, including menopause (ABCL635) and COVID-19 (Bamlanivimab, LY3819253) candidates showing recent clinical momentum and stock appreciation.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Bamlanivimab
COVID-19Clinical Trials (1)
NCT04603651Expanded Access Program to Provide Bamlanivimab (LY3819253) for the Treatment of COVID-19
N/AHelp build intelligence for AbCellera
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.